Skip to main content
. 2010 Oct;100(10):1953–1960. doi: 10.2105/AJPH.2009.174169

TABLE 3.

Adjusted Odds Ratios (AORs) Comparing Health Characteristics of Gay/Lesbian and Bisexual Participants to Those of Heterosexual Participants: Massachusetts Behavioral Risk Factor Surveillance Survey Respondents, 2001–2008

Gay/Lesbian vs Heterosexual
Bisexual vs Heterosexual
All
Men
Women
All
Men
Women
AOR (95% CI) P AOR (95% CI) AOR (95% CI) AOR (95% CI) P AOR (95% CI) AOR (95% CI)
Health care access
    No health insurance 1.17 (0.89, 1.53) .78 1.20 (0.86, 1.69) 1.12 (0.72, 1.73) 2.22 (1.55, 3.18) .28 2.76 (1.54, 4.94) 2.04 (1.32, 3.14)
    No regular provider 0.95 (0.73, 1.24) .05 0.80 (0.57, 1.11) 1.35 (0.87, 2.08) 2.04 (1.47, 2.81) .78 2.15 (1.26, 3.66) 2.02 (1.35, 3.03)
    No dental cleaning, prior year 1.13 (0.83, 1.54) .54 1.05 (0.73, 1.50) 1.29 (0.75, 2.23) 1.85 (1.21, 2.82) .86 1.75 (0.83, 3.71) 1.94 (1.19, 3.17)
General health
    Fair/poor self-rated health 1.19 (0.93, 1.52) .26 1.06 (0.74, 1.51) 1.39 (1.00, 1.95) 3.45 (2.39, 5.00) .56 4.03 (2.09, 7.76) 3.14 (2.02, 4.87)
    Activity limitation caused by disability 1.58 (1.31, 1.89) .08 1.37 (1.05, 1.80) 1.86 (1.45, 2.37) 3.68 (2.78, 4.88) .01 2.15 (1.31, 3.55) 4.54 (3.26, 6.33)
Weight < .01 .19
    Overweight 0.73 (0.61, 0.87) 0.54 (0.43, 0.68) 1.08 (0.83, 1.40) 0.92 (0.67, 1.27) 0.67 (0.38, 1.20) 1.11 (0.79, 1.57)
    Obese 0.91 (0.74, 1.11) 0.46 (0.34, 0.63) 2.05 (1.56, 2.69) 1.17 (0.81, 1.69) 0.93 (0.50, 1.74) 1.28 (0.82, 2.00)
Screening testsa
    HIV 3.62 (3.08, 4.26) < .01 6.84 (5.23, 8.97) 1.76 (1.42, 2.19) 2.72 (2.04, 3.63) .42 3.28 (1.99, 5.41) 2.29 (1.60, 3.26)
    Sigmoidoscopy or colonoscopyb 1.34 (0.99, 1.82) .07 1.67 (1.07, 2.61) 1.00 (0.66, 1.51) 1.28 (0.71, 2.32) .11 0.82 (0.36, 1.86) 2.16 (0.96, 4.86)
    Prostate-specific antigenc 0.69 (0.51, 0.93) 1.10 (0.51, 2.35)
    Mammogramc 1.63 (0.88, 3.02) 1.31 (0.70, 2.46)
    Papanicolau test, prior 3 years 0.84 (0.51, 1.38) 0.62 (0.32, 1.19)
Chronic health conditions
    Diabetes 1.04 (0.72, 1.50) .52 0.94 (0.56, 1.57) 1.23 (0.74, 2.06) 1.14 (0.61, 2.14) .92 1.21 (0.37, 3.96) 1.04 (0.62, 1.76)
    Heart disease 1.50 (0.83, 2.71) .68 1.37 (0.62, 3.03) 1.92 (0.95, 3.87) 2.19 (0.88, 5.43) .65 1.90 (0.65, 5.51) 2.24 (0.53, 9.43)
    Asthma 1.48 (1.23, 1.77) .21 1.32 (1.00, 1.73) 1.68 (1.32, 2.14) 1.39 (1.05, 1.85) .33 1.07 (0.57, 1.99) 1.58 (1.15, 2.18)
    High CVD risk 1.23 (0.98,1.55) .07 1.01 (0.73, 1.39) 1.63 (1.17, 2.26) 2.24 (1.47, 3.43) .96 2.25 (1.05, 4.79) 2.27 (1.36, 3.78)
Mental health
    Tense/worried ≥ 15 of prior 30 d 1.42 (1.08,1.86) .89 1.38 (0.93, 2.04) 1.46 (0.99, 2.15) 2.75 (1.91, 3.96) .92 2.69 (1.35, 5.36) 2.82 (1.83, 4.34)
    Sad/blue ≥ 15 of prior 30 d 1.26 (0.88, 1.81) .37 1.45 (0.89, 2.35) 1.02 (0.60, 1.75) 2.43 (1.56, 3.78) .68 2.08 (0.93, 4.68) 2.48 (1.47, 4.19)
    Seriously considered suicide, prior year 1.87 (0.96, 3.65) .56 2.13 (0.97, 4.66) 1.38 (0.35, 5.44) 11.28 (5.24, 24.28) .08 4.27 (0.82, 22.16) 20.56 (9.00, 47.00)
Substance use
    Cigarettes .05 .03
    Current smoker 2.33 (1.91, 2.84) 2.42 (1.88, 3.11) 2.20 (1.58, 3.07) 2.65 (1.95, 3.58) 2.03 (1.18, 3.49) 3.00 (2.10, 4.29)
    Former smoker 1.57 (1.32, 1.86) 1.39 (1.08, 1.78) 1.85 (1.46, 2.35) 1.21 (0.86, 1.71) 0.66 (0.38, 1.15) 1.57 (1.04, 2.37)
    Binge drinking, prior 30 d 1.16 (0.95, 1.42) .13 1.05 (0.84, 1.32) 1.43 (0.98, 2.09) 1.16 (0.83, 1.61) .05 0.78 (0.45, 1.34) 1.49 (1.02, 2.17)
    Illicit drug use, prior 30 d 2.76 (1.86, 4.08) .34 3.09 (1.85, 5.17) 2.14 (1.18, 3.87) 5.33 (2.92, 9.74) .06 2.28 (0.62, 8.39) 9.14 (4.54, 18.38)
Lifetime violence victimization
    Sexual assault 2.93 (2.17, 3.95) .15 3.72 (2.39, 5.79) 2.32 (1.60, 3.37) 3.87 (2.48, 6.05) .37 2.83 (1.29, 6.24) 4.36 (2.50, 7.61)
    Physical intimate partner 1.90 (0.82, 4.39) .6 2.44 (0.61, 9.70) 1.55 (0.65, 3.67) 2.62 (0.85, 8.09) .02 0.26 (0.03, 2.27) 7.91 (1.46, 42.70)

Note. CI = confidence interval; CVD = cardiovascular disease. The total sample size was N = 67 359. Odds ratios are adjusted for age, gender, and educational attainment; CIs are design-adjusted. All P values are χ-square P values for interaction to evaluate effect modification by gender.

a

Lifetime, unless otherwise noted.

b

Participants aged ≥ 50 years.

c

Participants aged ≥ 40 years.